Product
SARS-CoV-2
Aliases
SARS-CoV-2 vaccine
6 clinical trials
3 indications
Indication
COVID-19Indication
Kidney Transplant InfectionClinical trial
Phase Ⅱ Clinical Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (LVRNA009) in Chinese People Aged 18~59 YearsStatus: Completed, Estimated PCD: 2022-06-23
Clinical trial
Comparison of SARS-CoV-2, AdenoVIRus and Rhinovirus Infection of the Respiratory Epithelium in CHILdren vs. the eLDerlyStatus: Recruiting, Estimated PCD: 2025-04-28
Clinical trial
SARS-CoV-2 Cellular and Humoral Immune Response Following Vaccination of Kidney Transplant Recipients and Healthy ControlsStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
NGS Diagnostic in COVID-19 Hosts - Genetic Cause Relating to the Course of Disease ProgressionStatus: Completed, Estimated PCD: 2023-04-30
Clinical trial
Phase I Study Evaluating the Safety and Efficacy of the Protective Adjuvanted Inactivated Vaccine Developed Against SARS-CoV-2 in Healthy Participants, Administered as Two Injections Subcutaneously in Two Different Dosages.Status: Terminated, Estimated PCD: 2021-09-05
Clinical trial
Children's Hospital of Chongqing Medical UniversityStatus: Recruiting, Estimated PCD: 2023-06-30